Wat is de prijs voor OptiBiotix Health Plc (OPTI)

Het prijs van OptiBiotix Health Plc (OPTI) is $0.07994122

Wat is de marktkapitalisatie voor OptiBiotix Health Plc (OPTI)

Marktkapitalisatie voorOptiBiotix Health Plc (OPTI) is $82.58K

OptiBiotix Health Plc (OPTI) K/B-verhouding

OptiBiotix Health Plc, a life sciences enterprise headquartered in York, United Kingdom, specializes in the discovery and advancement of microbiome-modulating technologies. The company formulates distinct microbial strains, innovative compounds, and tailored blends intended for integration into food products, nutritional supplements, and active ingredients. Their groundbreaking work aims to positively influence human physiology and yield substantial health benefits. Among its diverse product portfolio are Slimbiome, a natural ingredient for healthy and satiety-driven weight management, and SlimBiome Medical, a supplemental aid for weight control. Other offerings include CholBiome, a dietary supplement for maintaining healthy cholesterol; Lactobacillus plantarum LPLDL, a probiotic supporting cardiovascular health and overall well-being; LPGOS, a galactooligosaccharide utilized in food applications to mitigate cardiovascular risk factors and enhance general health; WellBiome, a functional fiber and mineral blend designed to bolster gut microbiome diversity and promote wellness; and Sweetbiotix, a sweetener for use in various foods and beverages. Ultimately, OptiBiotix's innovations are designed to prevent and manage prevalent chronic lifestyle diseases, including obesity, high cholesterol, and diabetes. The company was founded in 2012.

Jaar	P/B-ratio	Wijzigen
2026 (TTM)	1.04	-50.35%
2024	2.10	-22.84%
2023	2.72	153.53%
2022	1.07	-51.71%
2021	2.22	-48.12%
2020	4.28	-62.38%
2019	11.38	3.97%
2018	10.94	27.05%
2017	8.61	-16.20%
2016	10.28	-37.65%
2015	16.49	1,187.68%
2014	1.28	11.90%
2013	1.14	-21.31%
2012	1.45	0.00%
2011	0.00	-100.00%
2010	0.36	4.78%
2009	0.34	1.84%
2008	0.34	0.00%
2007	0.00	0.00%

Jaar

P/B-ratio

Wijzigen

2026 (TTM)

1.04

-50.35%

2024

2.10

-22.84%

2023

2.72

153.53%

2022

1.07

-51.71%

2021

2.22

-48.12%

2020

4.28

-62.38%

2019

11.38

3.97%

2018

10.94

27.05%

2017

8.61

-16.20%

2016

10.28

-37.65%

2015

16.49

1,187.68%

2014

1.28

11.90%

2013

1.14

-21.31%

2012

1.45

0.00%

2011

0.00

-100.00%

2010

0.36

4.78%

2009

0.34

1.84%

2008

0.34

0.00%

2007

0.00

0.00%

Bedrijf	P/B-ratio	Verschil in P/B-ratio	Land
Vertex Pharmaceuticals Incorporated VRTX.US	6.5144	524.76%	US
Moderna, Inc. MRNA.US	8.5918	724.00%	US
Argenx SE ARGX.US	7.3983	609.53%	NL
CSL Limited CSL.AX	3.9974	283.37%	AU
Lonza Group AG LONN.SW	-	-	CH

Bedrijf

P/B-ratio

Verschil in P/B-ratio

Land